Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
12:55:47 EDT Sun 05 May 2024
Enter Symbol
or Name
USA
CA



News for U:ADIL from 2023-05-04 to 2024-05-03 - 28 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-22 08:30U:ADILNews ReleaseAdial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office
2024-04-10 08:30U:ADILNews ReleaseAdial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder
2024-04-02 08:30U:ADILNews ReleaseAdial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update
2024-03-01 19:00U:ADILNews ReleaseAdial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
2024-02-28 09:30U:ADILNews ReleaseAdial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office
2024-02-15 09:10U:ADILNews ReleaseAdial Pharmaceuticals to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20
2024-02-13 09:15U:ADILNews ReleaseAdial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office
2024-01-18 08:30U:ADILNews ReleaseAdial Announces Appointment of Tony Goodman as Chief Operating Officer
2023-12-20 09:00U:ADILNews ReleaseAdial Pharmaceuticals Receives Final Reimbursement Payment from Adovate
2023-11-29 16:05U:ADILNews ReleaseAdial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirement
2023-11-14 17:03U:ADILNews ReleaseAdial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
2023-10-31 08:30U:ADILNews ReleaseAdial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss ¢ € œNew Aspects in Substance Use Treatment ¢ €  at The Annual International Society of Addiction Medicine Conference
2023-10-25 08:00U:ADILNews ReleaseAddiction Experts Highlight the Need for Non-Abstinence-Based Therapies to Treat Alcohol Use Disorder in Adial Pharmaceuticals Key Opinion Leader Webinar
2023-10-24 16:30U:ADILNews ReleaseAdial Pharmaceuticals Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
2023-10-20 08:00U:ADILNews ReleaseAdial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
2023-10-19 12:02U:ADILNews ReleaseAdial Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference on October 25th
2023-10-19 10:31U:ADILNews ReleaseAdial Pharmaceuticals Awarded Notice of Allowance for Key Patent Combining Use of the Company ¢ € ™s Proprietary Genetic Diagnostic with AD04 to Treat Alcohol and Drug Dependence
2023-10-18 08:00U:ADILNews ReleaseAdial Pharmaceuticals Wins Frost & Sullivan's 2023 North American Precision Medicine for Addiction Disorders Technology Innovation Leadership Award
2023-09-28 07:00U:ADILNews ReleaseAdial Pharmaceuticals to Host a Virtual Key Opinion Leader Webinar to Discuss the Unmet Need in Alcohol Use Disorder
2023-09-05 08:30U:ADILNews ReleaseAdial Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
2023-08-28 08:30U:ADILNews ReleaseAdial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss the Need for New Alcohol Use Disorder Treatments at the European Society for Biomedical Research on Alcoholism
2023-08-23 08:30U:ADILNews ReleaseAdial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements
2023-08-21 08:30U:ADILNews ReleaseAdial Pharmaceuticals Reports Second Quarter 2023 Financial Results ‚  and Provides Business Update
2023-08-04 08:30U:ADILNews ReleaseAdial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq ¢ € ™s Minimum Bid Price Requirement and Reduce the Public Float
2023-07-11 08:30U:ADILNews ReleaseAdial Provides Business Update Following Favorable Comments from US and EU Regulatory Meetings
2023-06-01 09:00U:ADILNews ReleaseAdial Pharmaceuticals to Present at the 2023 Jefferies Global Healthcare Conference on June 9th
2023-05-12 08:30U:ADILNews ReleaseAdial Pharmaceuticals Reports First Quarter 2023 Financial Results ‚  and Provides Business Update
2023-05-10 08:30U:ADILNews ReleaseAdial Pharmaceuticals Receives Notice of Exercise from Adovate for the Acquisition of Purnovate ¢ € ™s Assets and Business